跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
洪 元
助理教授
,
心臟血管內科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學臺北心臟醫學研究中心
https://orcid.org/0000-0002-2199-8338
電子郵件
231017
h.tmu.edu
tw
h-index
387
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2026
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(34)
類似的個人檔案
(6)
指紋
查看啟用 Yuan Hung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Acute Coronary Syndrome
70%
Ablation
55%
Atrial Fibrillation
50%
Sinus Rhythm
39%
Cohort Analysis
36%
Ventricular Tachycardia
36%
Antithrombotic
36%
Long-Term Outcome
36%
Congestive Heart Failure
29%
Cardiac Dysrhythmia
27%
Endocardium
26%
Electrography
25%
Apoplexy
24%
Cardiovascular Disease
24%
Atrial Flutter
23%
Electrocardiography
22%
Ischemic Heart Disease
22%
Pulmonary Vein Isolation
22%
Antithrombotic Therapy
21%
CHA2DS2-VASc Score
20%
Cardiovascular System
20%
QTc Interval
20%
Computer Assisted Tomography
20%
Ventricular Outflow Tract
20%
Persistent Atrial Fibrillation
18%
Pacemaker Implantation
18%
New-Onset Atrial Fibrillation
18%
Fulminant
18%
Uterine Fibroid
18%
Hepatocellular Carcinoma
18%
Interventricular Septum
18%
Cigarette Smoking
18%
Myocarditis
18%
Heart Ventricle Arrhythmia
18%
Percutaneous Coronary Intervention
18%
Signal Analysis
18%
Drug-Eluting Stent
18%
Brugada Syndrome
18%
Zolpidem
18%
Observational Study
18%
Lymphocyte
18%
Paroxysmal Atrial Fibrillation
18%
Atrial Tachycardia
18%
Monocyte
18%
Neutrophil
18%
Risk Stratification
18%
Atrial Fibrillation Ablation
18%
Artificial Intelligence
18%
Stenting
15%
Electrocardiogram
14%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Cohort Study
56%
Anticoagulant Agent
36%
Heart Arrhythmia
25%
Chronic Kidney Failure
23%
All Cause Mortality
22%
Antithrombotic Therapy
21%
Paroxysmal Atrial Fibrillation
20%
Acute Coronary Syndrome
18%
Persistent Atrial Fibrillation
18%
Snakebite
18%
Propafenone
18%
Receptor
18%
Carbon Monoxide Poisoning
18%
Peripheral Occlusive Artery Disease
18%
Secretoneurin
18%
Cardiovascular Disease
18%
Protein Kinase B
18%
Diseases
18%
Lecithinase
18%
Pandemic
18%
Zolpidem
18%
Heart Ventricle Arrhythmia
18%
Coronavirinae
18%
Brain Hemorrhage
18%
Phosphatidylinositol 3 Kinase
18%
Indican
18%
Arrhythmogenesis
16%
Cerebrovascular Accident
16%
Antivenom
13%
Western Blot
12%
Antiplatelet
11%
Comorbidity
9%
Heart Muscle Conduction Disturbance
9%
Brain Ischemia
9%
Sick Sinus Syndrome
9%
Cardiovascular Risk
9%
Protein Kinase B Inhibitor
9%
Implant
9%
Congestive Heart Failure
8%
Hypertension
8%
Leporidae
7%
Bleeding
7%
Fibrosis
6%
Recurrent Disease
6%
1 [[6 (3 Methoxyestra 1,3,5(10) Trien 17beta Yl)amino]hexyl] 1h Pyrrole 2,5 Dione
6%
Antivitamin K
6%
Sodium
6%
Vitamin K Antagonist
6%
Nursing and Health Professions
Acute Coronary Syndrome
33%
Cohort Analysis
20%
Tertiary Care Center
18%
Heart Arrhythmia
18%
Drug Eluting Stent
18%
Lymphocyte Monocyte Ratio
18%
Ischemic Heart Disease
18%
Zolpidem
18%
Neutrophil Lymphocyte Ratio
18%
Stent
15%
Coronary Artery Disease
11%
Hospital Mortality
8%
Hazard Ratio
6%
Confidence Interval
6%
Mortality Rate
6%
Heart Disease
6%
Stable Angina Pectoris
6%
Cerebrovascular Accident
5%
